4412 — Science Arts Income Statement
0.000.00%
- ¥4bn
- ¥3bn
- ¥772m
Annual income statement for Science Arts, fiscal year end - August 31st, JPY millions except per share, conversion factor applied.
2019 August 31st | 2020 August 31st | 2021 August 31st | 2022 August 31st | 2023 August 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 179 | 223 | 366 | 660 | 772 |
Cost of Revenue | |||||
Gross Profit | 121 | 167 | 265 | 435 | 490 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 272 | 316 | 463 | 649 | 844 |
Operating Profit | -93.1 | -93.3 | -97.2 | 11.3 | -72.1 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -95.2 | -91.9 | -95.7 | 9.84 | -72.5 |
Provision for Income Taxes | |||||
Net Income After Taxes | -96 | -92.1 | -95.3 | 9.01 | -81.3 |
Net Income Before Extraordinary Items | |||||
Net Income | -96 | -92.1 | -95.3 | 9.01 | -81.3 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -96 | -92.1 | -95.3 | 9.01 | -81.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -15.8 | -15.2 | -15.7 | 1.34 | -11.9 |
Dividends per Share |